Congenital heart anomalies encompass structural abnormalities in the heart present at birth, arising during the intricate process of fetal heart development. Though the precise causes remain elusive, a combination of genetic predisposition, environmental factors, and specific maternal health conditions may contribute to their manifestation. These anomalies impact the heart's structure, involving chambers, valves, or blood vessels, thereby disrupting the normal blood flow and giving rise to diverse complications. Examples of congenital heart anomalies include but are not limited to atrial septal defects, ventricular septal defects, and tetralogy of Fallot. The severity of congenital heart anomalies varies, with some cases presenting as minor issues that may not necessitate immediate intervention, while others may demand surgical correction. Ongoing advancements in medical technology and surgical procedures have markedly enhanced the outlook for individuals affected by congenital heart anomalies. This progress facilitates early detection, timely intervention, and improved long-term outcomes.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States